Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pariser

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
Journal of the American Academy of Dermatology|January 19, 2016
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasisAmy S Paller, Elaine C Siegfried, David M Pariser, et al.
Dermatology and Therapy|July 8, 2021
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area ScoreKim A Papp, Mark G Lebwohl, Leon H Kircik, et al.
Journal of Patient-Reported Outcomes|September 6, 2019
Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severityL M Nelson, D DiBenedetti, D M Pariser, et al.
Journal of the American Academy of Dermatology|November 27, 2012
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studiesBoni E Elewski, Phoebe Rich, Richard Pollak, et al.
Journal of the American Academy of Dermatology|October 25, 2003
AAD consensus statement on psoriasis therapiesJeffrey P Callen, Gerald G Krueger, Mark Lebwohl, et al.
Journal of Cutaneous Medicine and Surgery|May 16, 2006
Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part IDavid M Pariser, Kenneth B Gordon, Kim A Papp, et al.
Clinical Therapeutics|May 1, 1995
Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasisH I Katz, J S Lindholm, J S Weiss, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patientsJohn Y M Koo, Alan B Fleischer, William Abramovits, et al.
The British Journal of Dermatology|January 23, 2023
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trialDiamant Thaçi, Ron Vender, Menno A de Rie, et al.
The Journal of Investigative Dermatology|April 21, 2020
TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled TrialSeth B Forman, David M Pariser, Yves Poulin, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Journal of the American Academy of Dermatology|January 19, 2016
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasisAmy S Paller, Elaine C Siegfried, David M Pariser, et al.
Dermatology and Therapy|July 8, 2021
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area ScoreKim A Papp, Mark G Lebwohl, Leon H Kircik, et al.
Journal of Patient-Reported Outcomes|September 6, 2019
Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severityL M Nelson, D DiBenedetti, D M Pariser, et al.
Journal of the American Academy of Dermatology|November 27, 2012
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studiesBoni E Elewski, Phoebe Rich, Richard Pollak, et al.
Journal of the American Academy of Dermatology|October 25, 2003
AAD consensus statement on psoriasis therapiesJeffrey P Callen, Gerald G Krueger, Mark Lebwohl, et al.
Journal of Cutaneous Medicine and Surgery|May 16, 2006
Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part IDavid M Pariser, Kenneth B Gordon, Kim A Papp, et al.
Clinical Therapeutics|May 1, 1995
Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasisH I Katz, J S Lindholm, J S Weiss, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patientsJohn Y M Koo, Alan B Fleischer, William Abramovits, et al.
The British Journal of Dermatology|January 23, 2023
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trialDiamant Thaçi, Ron Vender, Menno A de Rie, et al.
The Journal of Investigative Dermatology|April 21, 2020
TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled TrialSeth B Forman, David M Pariser, Yves Poulin, et al.
Pageof 20